CD40 and colitis: In an innate colitis model with anti-CD40 administration in RAG-1-/- mice, IL-22-neutralizing antibody significantly reduced the colon pathology, colitis scores and weight loss triggered by anti-CD40 injection, whereas IL-22 plasmid administration exacerbated colitis with infiltration of inflammatory cells and mucosal hyperplasia (30).